Skip to main content
NCBI home page
Oncotarget logoLink to Oncotarget
. 2022 Dec 6;13:1306. doi: 10.18632/oncotarget.28318

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study

Connor Willis 1,✉, Hillevi Bauer 1, Trang H Au 1, Jyothi Menon 1, Sudhir Unni 1, Dao Tran 2, Zachary Rivers 2, Wallace Akerley 3, Matthew B Schabath 4, Firas Badin 5, Ashley Sekhon 6, Malini Patel 7, Bing Xia 8, Beth Gustafson 9, John L Villano 10, John-Michael Thomas 11, Solomon J Lubinga 12, Michael A Cantrell 13, Diana Brixner 1, David Stenehjem 1,2
PMCID: PMC9726200  PMID: 36473137

This article has an addendum: This study proceeded with institutional IRB approvals at each participating cancer center. Due to the retrospective nature of this project, a waiver of informed consent was approved by each of the listed local IRBs.

Original article: Oncotarget. 2022; 13:257–270. 257-270. https://doi.org/10.18632/oncotarget.28178

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES